CLN0003_SL1 (SL1), a 50-mer DNA aptamer that specially binds to c-Met protein, is found to inhibit HGF-induced c-Met activation [25] and may efficiently mediate nanoparticle delivery into intracranial GBM. This evidence concerns the gene MET and glioblastoma.